Product
Enbrel
Aliases
(etanercept)
Name
ENBREL
FDA Approved
Yes
3 clinical trials
2 organizations
3 indications
1 document
Indication
Healthy Control ParticipantsIndication
Rheumatoid ArthritisIndication
Primary Systemic AmyloidosisClinical trial
A Randomized, Double-blind, Three-part, Two-period, Two-sequence, Single-dose, Cross-over Study to Compare the Pharmacokinetics (PK), Safety and Immunogenicity Profile of MB04 (Proposed Etanercept Biosimilar), EU-sourced Enbrel® and US Licensed Enbrel® in Healthy Male VolunteersStatus: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
Phase 1b Proof-of-concept, Open-label Study to Assess the Safety and Pilot Efficacy of Enbrel® Administered by the Sofusa® DoseConnect™ Delivery System for the Treatment of Rheumatoid ArthritisStatus: Active (not recruiting), Estimated PCD: 2024-01-01
Document
DailyMed Label: ENBRELOrganization
A-S Medication SolutionsOrganization
Immunex Corporation